Sugi Predict

Sugi Predict / Compounds / SCHEMBL58897

SCHEMBL58897

SCHEMBL58897

CC(=O)C(O)C(O)C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.42
▸ TSHR P16473 4/20 0.40
▸ THPO P40225 1/20 0.39
▸ FFAR3 O14843 1/20 0.39
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ TP53 P04637 1/20 0.38
▸ CA1 P00915 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ PMP22 Q01453 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14366518 1.00 LMNA (0.42) LMNATSHRTHPOFFAR3LCK
SCHEMBL16140166 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL16807867 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL10054702 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL8746197 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL437202 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL12654016 0.86 TSHR (0.67) LMNATSHRFFAR3LCKFYN
SCHEMBL5936391 0.84 LMNA (0.36) LMNATSHRTHPOFFAR3LCK
SCHEMBL12572606 0.84 LMNA (0.36) LMNATSHRTHPOFFAR3LCK
SCHEMBL13997319 0.84 LMNA (0.36) LMNATSHRTHPOFFAR3LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115417755-B Purification and cyclization process of 3, 4-dihydroxyl-2, 5-hexanedione 安徽金禾化学材料研究所有限公司 2023-11-17 — — CN claimed
CN-115417755-A Purification and cyclization process of 3, 4-dihydroxy-2, 5-hexanedione 安徽金禾化学材料研究所有限公司 2022-12-02 — — CN claimed
CN-110511129-B Method for synthesizing 3, 4-dihydroxy-2, 5-hexanedione by organic amine salt catalysis 厦门欧米克生物科技有限公司 2022-07-29 — — CN claimed
CN-110372646-B Preparation method of furanone 安徽金轩科技有限公司 2022-05-31 — — CN claimed
CN-113773286-A Synthetic method of furanone 昆山亚香香料股份有限公司 2021-12-10 — — CN claimed
CN-112852890-A Biological synthesis method of polyhydroxy diketone and hydroxy furanone compound 中国科学院天津工业生物技术研究所 2021-05-28 — — CN claimed
CN-110498782-B Continuous preparation method of 2, 5-dimethyl-4-hydroxy-3 (2H) furanone 厦门欧米克生物科技有限公司 2021-04-20 — — CN claimed
CN-110845313-A Continuous preparation method of 3, 4-dihydroxy-2, 5-hexanedione 厦门欧米克生物科技有限公司 2020-02-28 — — CN claimed
CN-110563676-A Preparation method of 2, 5-dimethyl-4-hydroxy-3 (2H) -furanone 安徽金禾实业股份有限公司 2019-12-13 — — CN claimed
CN-110511129-A A kind of method that organic amine salt catalyzes and synthesizes 3,4- dihydroxy -2,5- acetyl butyryl XIAMEN OAMIC BIOTECH CO LTD 2019-11-29 — — CN claimed
CN-109879742-A A kind of preparation method of 3,4- dihydroxy -2,5- acetyl butyryl 安徽金禾实业股份有限公司 2019-06-14 — — CN claimed
CN-108911957-A A kind of preparation method of 2,5- acetyl butyryl 枣庄九星生物科技有限公司 2018-11-30 — — CN claimed
US-7345206-B2 promoted by an alkaline salt of the hydroxymethanesulfinic acid and is performed at a pH comprised between 3.5 and 9.5; for the preparation of 1,4-dione-2,3-diols FIRMENICH SA (CH) 2008-03-18 — — US claimed
US-20070185352-A1 NEW PROCESS FOR THE DIMERISATION OF ALKYL GLYOXALS FIRMENICH SA (CH) 2007-08-09 — — US claimed
EP-1812369-A1 A NEW PROCESS FOR THE DIMERISATION OF ALKYL GLYOXALS FIRMENICH SA (CH) 2007-08-01 — — EP claimed
WO-2006048792-A1 A NEW PROCESS FOR THE DIMERISATION OF ALKYL GLYOXALS FIRMENICH SA (CH) 2006-05-11 — — WO claimed
US-6642170-B1 Metals selected from tantalum, vanadium, niobium, chromium, molybdenum or tungsten on catalyst supports such as zeolites, oxides of silicon, aluminum, titanium, titanium, niobium or tantalum, used for etherification of alcohols-2+ CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2003-11-04 — — US claimed
US-20020111500-A1 Preparation of 4-hydroxy-3[2H]-furanones MAXYGEN, INC. 2002-08-15 — — US claimed
EP-1109623-A1 NOVEL SOLID OXIDATION CATALYSTS, IN PARTICULAR FOR EPOXIDATION OF PROCHIRAL COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2001-06-27 — — EP claimed
WO-2000003802-A1 NOVEL SOLID OXIDATION CATALYSTS, IN PARTICULAR FOR EPOXIDATION OF PROCHIRAL COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2000-01-27 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111500-A1 Preparation of 4-hydroxy-3[2H]-furanones HPD, CYP4X1, HAAO LMNA 3694/4885TSHR 4598/4885THPO 1121/4885
US-20070185352-A1 NEW PROCESS FOR THE DIMERISATION OF ALKYL GLYOXALS GLO1, GRHPR, HAO2 LMNA 2830/4885TSHR 4821/4885THPO 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.